The PE Ratio as of July 2024 (TTM) for Structure Therapeutics Inc. (GPCR) is -17.18

According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -17.18. This represents a change of -8.10% compared to the average of -18.69 of the last 4 quarters.

Structure Therapeutics Inc. (GPCR) Historical PE Ratio (quarterly & annually)

How has GPCR PE Ratio performed in the past?

The mean historical PE Ratio of Structure Therapeutics Inc. over the last ten years is -21239.34. The current -17.18 PE Ratio has changed -91.91% with respect to the historical average. Over the past ten years (40 quarters), GPCR's PE Ratio was at its highest in in the March 2023 quarter at -7.90. The PE Ratio was at its lowest in in the December 2021 quarter at -10734.55.

Structure Therapeutics Inc. (GPCR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Structure Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Structure Therapeutics Inc. (GPCR) Average PE Ratio

How has GPCR PE Ratio performed in the past?

The current PE Ratio of Structure Therapeutics Inc. (GPCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Structure Therapeutics Inc. (GPCR) PE Ratio vs. Peers

How is GPCR’s PE Ratio compared to its peers?

Structure Therapeutics Inc.’s PE Ratio is less than Day One Biopharmaceuticals, Inc. (-6.65), less than X4 Pharmaceuticals, Inc. (-1.34), less than Inozyme Pharma, Inc. (-4.67), less than Acumen Pharmaceuticals, Inc. (-3.72), greater than Mereo BioPharma Group plc (-82.75), less than Terns Pharmaceuticals, Inc. (-7.36), less than Amylyx Pharmaceuticals, Inc. (-1.88), less than Eledon Pharmaceuticals, Inc. (-2.22), less than HOOKIPA Pharma Inc. (-16.23), less than Biomea Fusion, Inc. (-1.56), less than Disc Medicine, Inc. (-14.06), greater than DICE Therapeutics, Inc. (-23.17), less than Morphic Holding, Inc. (-15.75),

Build a custom stock screener for Structure Therapeutics Inc. (GPCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Structure Therapeutics Inc. (GPCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.